Candel Therapeutics, Inc. (CADL) vs Wave Life Sciences Ltd. (WVE)

A side-by-side comparison of Candel Therapeutics, Inc. and Wave Life Sciences Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CADL vs WVE

growth of $100 · dividends reinvested · last 5y
CADL +46.1% (+7.9%/yr)WVE -31.6% (-7.3%/yr)CADL compounded faster over this window
0100200300Start $10020222023202420252026$146$68
CADL WVE

CADL vs WVE: by the numbers

  • •CADL is the larger company ($723M vs $694M market cap).
  • •Both run net losses; CADL's is the smaller (0.00% vs -309.73% net margin).

Metrics side by side

Valuation

MetricCADLWVE
P/S ratioN/A10.61
P/B ratio5.731.53

Profitability

MetricCADLWVE
Gross margin0.00%79.28%
Operating margin0.00%-504.09%
Net margin0.00%-309.73%
ROE-70.19%-44.64%
ROIC-36.83%-42.94%

Growth (annualized)

MetricCADLWVE
Revenue CAGR (5Y)N/A33.08%
Total return CAGR (5Y)-1.42%-4.33%

Frequently asked

How have CADL and WVE total returns compared?
Over the past 5 years, CADL delivered -1.42% and WVE delivered -4.33% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.